Disclosures for "Nipocalimab a High Affinity, Immunoselective Clinical FcRn Blocker with Unique Properties: Observations from Non-clinical and Clinical Studies"
-
Dr. Seth has received personal compensation for serving as an employee of J&J Innovative Medicines .
-
Dr. Xu has nothing to disclose.
-
Mr. Tyler has received personal compensation for serving as an employee of AVROBIO, INC . Mr. Tyler has received personal compensation for serving as an employee of Orna Therapeutics. Mr. Tyler has received personal compensation for serving as an employee of Genevant Sciences.
-
Dr. Avery has received personal compensation for serving as an employee of Lyndra Therapeutics. Dr. Avery has received personal compensation for serving as an employee of Xilio Therapeutics. Dr. Avery has received personal compensation for serving as an employee of Kisbee Therapeutics. Dr. Avery has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta Pharmaceutical. Dr. Avery has received stock or an ownership interest from Life Biosciences.
-
Mr. Beavers has received personal compensation for serving as an employee of Johnson & Johnson. Mr. Beavers has stock in Apple. Mr. Beavers has stock in Amazon.
-
Mr. Parge has received personal compensation for serving as an employee of Johnson and Johnson Innovative Medicine. Mr. Parge has stock in Johnson and Johnson Innovative Medicine.
-
-
Dr. Brown has received personal compensation for serving as an employee of Janssen Pharmaceuticals. Dr. Brown has received personal compensation for serving as an employee of Momenta Pharmaceuticals. Dr. Brown has received stock or an ownership interest from Janssen Pharmaceuticals. Dr. Brown has received stock or an ownership interest from Momenta Pharmaceuticals. Dr. Brown has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Bhattacharya has nothing to disclose.
-
Dr. Ramchandren has received personal compensation for serving as an employee of Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Ramchandren has a non-compensated relationship as a Scientific Advisory Board Member with CMT Research Foundation (CMTRF) that is relevant to AAN interests or activities.
-
Dr. Heerlein has received personal compensation for serving as an employee of Johnson and Johnson Innovative Medicine. Dr. Heerlein has stock in Johnson and Johnson Innovative Medicine.
-
Dr. Sun has received personal compensation for serving as an employee of Janssen.
-
-
Dr. Ling has received personal compensation for serving as an employee of Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has stock in Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has received intellectual property interests from a discovery or technology relating to health care. Dr. Ling has received intellectual property interests from a discovery or technology relating to health care.